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Abstract
Background: Postural hypotension (PH), the reduction in blood pressure when rising from sitting or lying 0to
standing, is a risk factor for falls, cognitive decline and mortality. However, it is not often tested for in primary care.
PH prevalence varies according to definition, population, care setting and measurement method. The aim of this
study was to determine the prevalence of PH across different care settings and disease subgroups.
Methods: Systematic review, meta-analyses and meta-regression. We searched Medline and Embase to October
2019 for studies based in primary, community or institutional care settings reporting PH prevalence. Data and study
level demographics were extracted independently by two reviewers. Pooled estimates for mean PH prevalence
were compared between care settings and disease subgroups using random effects meta-analyses. Predictors of PH
were explored using meta-regression. Quality assessment was undertaken using an adapted Newcastle-Ottawa
Scale.
Results: One thousand eight hundred sixteen studies were identified; 61 contributed to analyses. Pooled prevalences
for PH using the consensus definition were 17% (95% CI, 14–20%; I2 = 99%) for 34 community cohorts, 19% (15–25%;
I2 = 98%) for 23 primary care cohorts and 31% (15–50%; I2 = 0%) for 3 residential care or nursing homes cohorts
(P = 0.16 between groups). By condition, prevalences were 20% (16–23%; I2 = 98%) with hypertension (20 cohorts), 21%
(16–26%; I2 = 92%) with diabetes (4 cohorts), 25% (18–33%; I2 = 88%) with Parkinson’s disease (7 cohorts) and 29%
(25–33%, I2 = 0%) with dementia (3 cohorts), compared to 14% (12–17%, I2 = 99%) without these conditions (P < 0.01
between groups). Multivariable meta-regression modelling identified increasing age and diabetes as predictors of PH
(P < 0.01, P = 0.13, respectively; R2 = 36%). PH prevalence was not affected by blood pressure measurement device
(P = 0.65) or sitting or supine resting position (P = 0.24), however, when the definition of PH did not fulfil the consensus
description, but fell within its parameters, prevalence was underestimated (P = 0.01) irrespective of study quality (P = 0.04).
Conclusions: PH prevalence in populations relevant to primary care is substantial and the definition of PH used is
important. Our findings emphasise the importance of considering checking for PH, particularly in vulnerable populations,
to enable interventions to manage it. These data should contribute to future guidelines relevant to the detection and
treatment of PH.
PROSPERO:CRD42017075423.
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Background
Postural, or orthostatic, hypotension (PH), is the fall in
blood pressure (BP) when rising from seated or supine
to standing [1]. It is associated with an increased risk of
falls, cognitive decline, reduced quality of life and
mortality [2–5].
Current National Institute for Health and Care Excel-
lence (NICE) hypertension guidelines advise testing for
PH in the presence of type 2 diabetes, postural symp-
toms or aged 80 or over [6]; European guidelines also
suggest checking in older people and those with diabetes
[7]. Whilst PH is routinely tested for in primary care
when symptoms are reported, we have found that it is
only considered one third of the time for older people
and rarely with diabetes, in the absence of symptoms [8].
Since the majority of people with PH are asymptomatic,
they are likely to go undetected under current practices,
placing them at avoidable risk of sequelae [5, 9].
In 2011, a consensus definition for PH: a sustained re-
duction in systolic BP ≥20 mmHg or diastolic BP ≥10
mmHg within 3 min of rising to a standing position, was
proposed [1]. However, many other definitions of PH
exist; reported prevalence estimates are likely dependent
on the definition used, making this a source of variance
and uncertainty around diagnosis of PH. Prevalence may
also vary depending on the method of BP measurement,
population and care setting under investigation. The
prevalence of PH has been reported as ranging from 2 to
57% in community settings, primary care and institu-
tional care cohorts [4, 10, 11]; increasing prevalences
have been associated with older age, diabetes and hyper-
tension [9, 12–14].
The large variation of reported prevalences may create
uncertainty for clinicians as to who should be assessed
for PH [15]. By describing the prevalences of PH in set-
tings and conditions relevant to primary care, and iden-
tifying factors associated with greater prevalences, we
aim to raise awareness of those patients most likely to
have asymptomatic PH. Such evidence could counteract
clinical inertia and facilitate rational choices, in the face
of rising workload, as to when to invest time in testing
for PH [16, 17]. Increased recognition of PH would per-
mit appropriate interventions, such as review of medica-
tions, to reduce risks of falls and other sequelae [18].
We undertook the following systematic review, meta-
analyses and meta-regression to address these questions.
Methods
Literature searches
A systematic review was undertaken to determine the
prevalence of postural hypotension across care settings.
This study was prospectively registered with PROS-
PERO: CRD42017075423. We searched Medline (includ-
ing Medline in Process and Old Medline) and Embase
from their respective commencement dates until 1st Oc-
tober 2019, using a broad search strategy based on key
search terms (Appendix 1). Further studies were identi-
fied from the authors’ archives and from reference lists
of included studies and review articles. Study titles and
abstracts were screened independently by two authors.
Disagreements were discussed to reach consensus, with
provision for adjudication by a third author, if needed.
Two authors assessed and agreed full texts for inclusion,
undertook data extraction and assessed study quality;
the review process was managed using Covidence
(Veritas Health Innovation, Melbourne, Australia).
Inclusion and exclusion criteria
Studies were eligible for inclusion if BP was measured in
a lying or seated position followed by standing and using
either a manual or automated sphygmomanometer. Eli-
gible study settings were primary care, community or
residential/nursing home populations. We identified 78
distinct definitions of PH in scoping studies for this re-
view. To minimise heterogeneity of findings due to defi-
nitions, we restricted inclusion to studies which either
reported using the consensus definition or adopted a
definition encompassed within the consensus definition
[1]. Exclusion criteria are summarised in Table 1.
Data extraction
Study level demographics were extracted for care setting,
mean age, BP measurement device, resting position
(seated or supine) and medical history of hypertension,
diabetes, Parkinson’s disease or dementia. Where a range
of health status existed within a study population, if
more than 50% of the total cohort included individuals
with a particular condition, hypertension, for example,
we applied the appropriate disease classification, i.e. the
cohort would be classed as a hypertensive cohort. Popu-
lations were included within the community category,
unless specifically selected from a primary care or insti-
tutional care setting. The Newcastle-Ottawa Scale
(NOS), with questions adapted to PH specific context,
was used to assess study quality (Appendix 2). Where
multiple reports for a cohort were retrieved, extraction
was primarily taken from the main publication, with
addition of detail from subsidiary reports where needed.
Table 1 Exclusion criteria for review
• Definition of PH incompatible with consensus definition
• Studies where PH was provoked by tilt table testing or pain
stimulation
• Studies using continuous or ambulatory BP monitoring for diagnosis
of PH
• Drug trials
• Specific but specialised cohorts, e.g. spinal injuries, multiple sclerosis
or HIV
• Studies from secondary and tertiary care settings
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Statistical analysis
Pooled estimates of mean prevalences for PH were cal-
culated and compared between settings and populations
using meta-analysis of proportions, undertaken in Stata
v16 (Statacorp, Texas, USA) [19]. Random effects
models were used throughout due to anticipated hetero-
geneity between included studies. Statistical heterogen-
eity was assessed using the I2 statistic, and explored with
sensitivity analyses, using meta-analysis, based on care
setting, disease status or BP measurement method. We
also conducted sensitivity analyses according to the def-
inition of PH, i.e. whether PH was reported using the
consensus definition or a definition that fell within the
consensus definition parameters but did not fully meet
them (e.g. by measuring BP over less than three minutes
of standing). Univariable meta-regression analyses were
undertaken to examine association between study level
factors [mean age, percentage of females, mean absolute
resting systolic BP, care setting, BP measurement
method (auscultatory or oscillometric) or position
(seated or supine), disease status (hypertension, diabetes,
Parkinson’s disease or dementia)] and prevalence of PH
[20]. Factors suggesting univariable associations with PH
(using P < 0.1) were entered into multivariable models,
with a priori inclusion of age, care setting and presence
of diabetes and hypertension. Publication bias was
assessed visually using funnel plots and quantified with
the Egger test [21].
Results
Searches identified 1816 unique citations; 356 full texts
were reviewed; 92 studies met inclusion criteria, but only
61 fell within the consensus definition of PH, thus con-
tributing to the meta-analyses. Reasons for the exclusion
of studies are summarised in Fig. 1.
Description of studies
All included studies were cross-sectional or cohort stud-
ies, with cohort size ranging from 40 to 32,797 partici-
pants (Table 2). On quality assessment, areas of low
quality (defined as falling below the median NOS total
Fig. 1 Flow chart illustrating the process of inclusion or exclusion in this prevalence of postural hypotension systematic review
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Table 2 Studies included in meta-analysis for consensus definition of postural hypotension
Study Subjects Age (mean or range;
years)
BP measurement method Prevalence
of PH (%)
Institutional care
Reported as consensus definition of PH
Hommel
2016 [22]
Male and female nursing home residents in the
Netherlands, receiving long term care and using
antiparkinsonian medication
78.8 After 10 min of supine rest and at 1
and 3 min after standing up, BP was
measured using a routine
sphygmomamometer
51.6
Not reported but fits consensus definition of PH
Enrique Asensio
2011 [23]
Male and female Mexican residents of public or
private care institutions, aged over 65 years and
able to sign informed consent
82.4 After 5 min of seated rest and at 1
and 3 min of standing up, BP was





Male and female nursing home residents in
France and Italy, aged over 80 years and able to
sign informed consent
88 After 10 min of seated rest and at 1
and 3 min of standing up, BP was
measured using the Colson DM-H20
automated oscillometric device
(Dupont Médical, Frouard, France). All
measurements were repeated three
times, with intervals of 3 min on the
left arm in a sitting position
18.0
Primary care
Reported as consensus definition of PH
Bouhanick
2014 [25]
Male and females living in France with type 2
diabetes, aged over 70 years with relatively
preserved autonomy (Activity of Daily Living
Score > 3/6)
77.0 After 5 min of supine rest and at 1, 3
and 5 min after standing up, BP was





Male and female participants with type 2 diabetes
and a glycohaemoglobin level ≥ 7.5%, aged
40–79 years with cardiovascular disease or aged
55–79 years with anatomic evidence of subclinical
atherosclerosis, albuminuria, left ventricular
hypertrophy or ≥ 2 additional risk factors for
cardiovascular disease, attending 77 sites across
the U.S.A and Canada
40.0–79.0 BP was measured three times, at 1
min intervals, after 5 min of seated
rest and on standing, using an
automated oscillometric device





Male and female participants with type 1 or 2
diabetes living in Wisconsin
45.4 BP was measured using a standard
mercury sphygmomanometer during
supine rest and repeated within 3 min





Male and female participants with Parkinson’s
disease (Hoehn and Yahr stage I-IV), stable on
drug therapy or not received any drug
modifications for 4 weeks prior to enrolment,
attending King Chulalongkorn, Thailand
65.5 After 10 min of seated or supine rest,
and within 3 min of standing, BP was






Male and female participants (from the
Amsterdam Dementia cohort) with subjective
cognitive decline, mild cognitive impairment or
dementia attending a memory clinic.
63.9 After 5 min of supine rest, and at 1
and 3 min after standing, BP was





Male and females with idiopathic Parkinson’s
disease (Hoehn and Yahr stage I-IV), aged 30–85
years, on dopaminergic treatment for at least
4 weeks prior to study enrolment, attending two
specialised Movement Disorder Centres in the
USA and Italy
30.0–85.0 After 10 min of seated and supine rest
and at 1 and 3 min after standing, BP
was measured in the left arm using
an automated sphygmomanometer
(Omron, HEM-7200; Omron Healthcare
Co. Kyoto, Japan). The average of two
BP measurements were used for both




Male and female participants, with idiopathic
Parkinson’s disease, aged between 30 and
85 years old, attending a Movement Disorder
Center in Italy. Participants must have been
taking stable doses of dopaminergic treatment
for at least 4 weeks prior to enrolment in the study
65.06 BP was measured after 10 min supine
rest and at 1, 3 and 5 min after





Male and female participants with first time
diagnosis of mild dementia (mini mental state
n/a After supine rest (or in some cases,
seated rest) and then once within 3
31.0
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Table 2 Studies included in meta-analysis for consensus definition of postural hypotension (Continued)
Study Subjects Age (mean or range;
years)
BP measurement method Prevalence
of PH (%)
score of at least 20) with referrals to outpatient
clinics in geriatric medicine, old age psychiatry
and neurology and living in Norway





Male and female veterans attending an urban
Medical Centre, U.S.A
21.0–88.0 After 10 min supine rest and during
10 min of standing, BP was measured
in the right arm at 1 min intervals
using an automated
sphygmomanometer (Dynamap Pro
300; GE Healthcare, Buckinghamshire,
UK)
14.0
Not reported but fits consensus definition of PH
Alli
1992 [34]
Male and female participants aged over 65 years,
attending general practices in Italy
72.7 BP was measured in the sitting
position, after 5 min of supine rest





Male and female participants aged over 65 years,
attending the outpatient clinic of Ankara
University School of Medicine, Department of
Geriatric Medicine, Turkey
68.0 After 20 min of supine rest and 3 min
after standing, BP was measured




154 male and female dementia patients (50 with
Alzheimer’s disease, 54 with Alzheimer’s disease
with vascular components, 50 with dementia
with Lewy bodies) attending a Memory Clinic
and 50 controls, in Sweden
n/a After 10 min of supine rest,
immediately after standing and at 1,
3, 5 and 10 min of standing, BP was
measured using a validated digital
sphygmomanometer (Omron M5–1;




Male and female participants aged over 55 years,
living in Portugal, attending primary healthcare
centres in the community
n/a After 5 and 7min of seated rest, and
at 2 and 5 min after standing, BP was





Male and female participants, with incident,
drug-naïve Parkinson’s disease, residing in
Southern and Western Norway
67.8 BP was measured in a supine position





Females aged 60–80 years of age, living in the
U. K and attending general practices
60.0–80.0 Two sitting BP measurements,
followed by two standing
measurements were recorded at 1





Male and female patients with Parkinson’s
disease, aged over 50 years, attending the
outpatient clinic of the Department of
Neurodegeneration, University of Tübingen,
Germany
> 50.0 After 2 min supine rest and after 2





Male and female participants attending a
community health centre in Chengdu, China
64.8 After 5 min of seated rest, BP was
measured in the right arm, twice (at 1
min apart) using a calibrated
electronic device (Omron HEM-7200;
Omron Healthcare Co. Kyoto, Japan).
After 10 further min of supine rest,
and at 30 s and 2 min after standing,
BP was recorded again and these





Individuals living in Japan, aged ≥65 years with
normotension (≤ 140/90 mmHg) or established
hypertension (160/95 mmHg) treated with
calcium channel blockers, beta blockers, alpha
blockers, angiotensin converting enzyme
inhibitors or diuretics after a 1 month placebo
run-in period
≥ 65.0 BP was measured after 5 min of
seated rest, 10 min supine rest and
after standing for 2 min (in this order).




Male and female patients, aged over 70 years,
who visited a hospital in Japan for day care,
programmed for those with dementia
84.0 BP was measured using a validated
electronic device (Parama-Tech PS-
501) in the supine position after a few
minutes of rest and immediately on
standing and at 1, 3 and 5 min after
26.6
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Table 2 Studies included in meta-analysis for consensus definition of postural hypotension (Continued)
Study Subjects Age (mean or range;
years)





Male and female patients, aged over 80 years,
able to stand for 5 or more minutes and
attending an urban primary health care centre
or treated at home by a family doctor or nurse
were included
85.2 After 5 min of rest in the supine
position, 2 separate BP readings were
taken 1min apart, and then BP was
measured immediately on standing
and at 1, 3 and 5 min after standing,
using a validated and calibrated
oscillometric Omron 705-CP device




Male and female patients, aged ≥70 years, with
type 2 diabetes attending general practices in
the Netherlands
75.0 After 5 min of rest, two BP
measurements were performed in the
supine position and at 1 and 3 min
following standing, using a validated
A&D digital monitor (UA-767 plus 30).
The mean of the two measurements




Male and female individuals, aged 63–93 years
attending a day centre
63.0–93.0 After 20 min of supine rest and after
2 min of standing, BP was measured




Multiethnic Asian ambulatory male and female
patients, aged ≥65 years, attending a typical
public primary care clinic located in the
mideastern part of Singapore
74.6 After 5 min of supine rest, BP was
measured 3 times in the right arm. In
addition, BP was measured at 1 and 3
min following standing using a
calibrated DINAMAP BP machine




Reported as consensus definition of PH
Cremer
2017 [47]
Male and female participants, aged over 65 years,
living in three cities in France (Bordeaux, Dijon
and Montpellier.)
> 65.0 After 5 min of supine rest and
immediately on standing, BP was
measured once using an automated
oscillometric device (Omron CP750,




Male and female participants, aged over 18 years,
with New York Heart Association class II-III
chronic heart failure, with left ventricular ejection
fraction < 40% under stable conditions, with no
cardiovascular interventions in the past 3 months
and stable on pharmacological treatment in the
4 weeks prior to study enrolment
63.3 After 10 min of supine rest and within
3 min of standing, BP was measured
using a validated oscillometric device





Male and female participants, aged at least
75 years, using antihypertensive medication, with
a systolic BP 160 mmHg or less and a Mini Mental
State examination score of 21–27. Participants
were residing in the Netherlands and did not
have serious cardiovascular disease or a clinical
diagnosis of dementia
81.0 After 5 min of seated rest, BP was
measured twice (separated by 1–2
min) and within 3 min of standing, BP
was measured 3 times, on the right
arm. An automatic electronic
sphygmomanometer (Omron M6





Male and female home-dwelling participants,
aged over 75 years, living in Kuopio in Eastern
Finland
81.0 After 10 min of rest, BP was measured
in the supine, seated and standing
positions (at 1 and 3min) by a trained





Male and female participants, aged 20–90 years,
of mixed socioeconomic status, living in Kurnool
and Kadapa district urban areas of India.
Participants were non-smokers and free of any
cardiorespiratory disease
20.0–90.0 BP was measured in the right arm
using a mercury sphygmomanometer
after 5 min of supine rest and at 1
and 3 min following standing. The





Male and female participants aged over 55 years,
residing in Venezuela
66.7 BP was measured in the supine
position and at 1 and 3 min after
standing using the same oscillometric
device (Dinamap 8100, Critikon Inc.,
Tampa, FL, USA)
19.3
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Table 2 Studies included in meta-analysis for consensus definition of postural hypotension (Continued)
Study Subjects Age (mean or range;
years)




Male and female participants, aged 60 years or
older, able to communicate and sit and stand
in 3 min, residing in Ben Tre, a Southern Province
Vietnam
70.4 After at least 15 min of rest, two
seated BP measurements were
obtained, separated by 5 min. The
mean of the two sitting BPs were
used for analysis. BP measurements
were repeated after standing for 3
min. BP was measured using a
calibrated Omron electronic
sphygmomanometer (model HEM




Male and female participants, aged
70 years or older, residing in Tanzania
72–80 BP was measured using a calibrated
A&D Medical UA-1020 Digital BP
monitor in the supine position,





Elderly male and female participants living
in Canada
83.2 BP was measured in supine and
standing positions (or seated in those





Male and female participants, aged
≥65 years, living in Italy
73.8 BP was measured 3 times in the right
arm, with 30 s between each
measurement, using a mercury
sphygmomanometer (Erkameter 300)
with subjects in a supine position. BP
measurements were also recorded at




Male and female participants, aged ≥55 years,
from the Ommoord area, a suburb of Rotterdam,
Netherlands
68.5 After 5 min of supine rest, the mean
of 2 BP measurements were recorded.
BP was also recorded following 1, 2




Not reported but fits consensus definition of PH
Assantachai
1998 [58]
Male and female participants, aged over 60 years,
living in Bangkok and able to perform postural
change from lying to standing by themselves
60.0–96.0 After 10 min of supine rest, BP was
measured twice using a digital
sphygmomanometer. BP was then





Male and female participants, aged 45–64 years,
living in 4 U.S.A communities: Forsyth County,
Jackson, suburban Minneapolis and
Washington County
54.0 After 20 min of supine rest, BP was
measured every 30 s for 2 min (2–5
measurements, 90% of participants
had ≥4 measurements) using a
Dinamap 1846 SX automated
oscillometric device. BP was then
measured repeatedly for the first 2
min after standing (2–5





Male and female community-dwelling individuals,
aged over 65 years, living in 4 U.S.A communities:
Pittsburgh, Forsyth County, Sacramento County
and Washington County
73.0 After at least 20 min of supine rest
and after 3 min of standing, BP was
measured using a mercury
sphygmomanometer (Baumanometer,




Male and female patients with Parkinson’s disease
for ≥20 years
n/a BP protocol or device not reported 16.0
Cohen
2015 [11]
Male and female participants, aged over 65 years,
independent in ambulation and attending a
primary care clinic in Israel
73.6 BP was measured every min during
10 min of supine rest and within 1
min of standing and repeated at 1
min intervals another 6 times. BP was
measured using an automatic Scholar





Male and female community-dwelling individuals,
aged ≥65 years, living in Camposampiero and
Rovigo, Italy
71.4 After at least 5 min of supine rest, BP
was measured 3 times in the right
arm, at 30 s intervals, using a mercury
18.3
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Table 2 Studies included in meta-analysis for consensus definition of postural hypotension (Continued)
Study Subjects Age (mean or range;
years)
BP measurement method Prevalence
of PH (%)
sphygmomanometer (Erkameter 300).




Female participants, aged over 65 years, residing
in the U.S.A: Portland, Minneapolis, Baltimore
and Monongahela Valley, near Pittsburgh
71.7 After 5 min of supine rest and after 1
min of assuming a standing position,
BP was measured in the right arm





Male and female rural community residents, aged
40–75 years, living in Xinyang County, China
40.0–75.0 After 15 min of supine rest, BP was
measured 3 times in the right arm at





Middle-aged male and female individuals, living
in Sweden
45.7 After 10 min of supine rest and at 1
min after standing up, BP was





Community-dwelling male and female individuals,
aged over 50 years, living in the Republic of Ireland
63 After 30 min of seated rest, 2 BP
measurements were recorded,
separated by 1 min, using an
automatic digital BP monitor (Omron
M10-IT; Omron Healthcare Co. Kyoto,
Japan). After 1 min of standing, a sin-





Male and female individuals, aged over
70 years, who were able to understand and
communicate in English, walk 20 ft. without
assistance and living in Boston, U.S.A
78.1 After 5 min of supine rest, 2 BP
measurements were recorded,
separated by 1 min, using a standard
sphygmomanometer. The mean of
the 2 measurements were used for
analysis. BP was also recorded at 1




Male and female participants, aged ≥75 years,
living in Kuopio, Finland, including mainly
home-dwelling individuals, but part of the sample
were living in institutional care
≥ 75.0 BP was measured after 10 min of rest
in the supine position, 1 min after
sitting and after 1 and 3 min of
standing using an electronic
sphygmomanometer or mercury





Male and female home-dwelling participants,
aged over 70 years, living in 5 rural
municipalities in northern Finland
76.0 After 5 min of supine rest and at 1
and 3 min after standing up, BP was





Male and female home care clients, aged over
75 years, living in Eastern and Central Finland
84.5 After 10 min of supine rest, the first BP
was measured. The second BP was
measured in the seated position,
followed further BP measurements at





Independent, community living individuals, aged
over 55 years who utilise the free health screening
services of Santa Monica Senior Health and Peer
Counseling Center, U.S.A
69.8 After 5 min of supine rest, 3 BP
measurements were recorded over a
5 min period using a mercury
manometer (Baumanometer). The
mean of the second and third BP
measurements were used. BP was also




Males of Japanese ancestry, aged 45–68 years
and living on the island of Oahu, Hawaii
71–93 After at least 15 min of supine rest
and after 3 min of standing, BP was





Community-dwelling male and female individuals,
aged over 50 years, living in the Republic of Ireland
63.0 After at least 30 min of seated rest, 2
BP measurements were recorded and
the mean was used for analysis. A
single BP measurement was also
recorded after 1 min of standing using
an automated BP device (Omron
6.1
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score of 8; range: 3–10) were notable in categories
relating to the response rates of participants and in
comparability between respondents and non-respondents
(usually due to lack of information provided), and the
use of non-validated methods for BP measurement
(Table 3.).
Reported prevalences
Overall, PH prevalence using the consensus definition was
18% (95% confidence interval, 16–21%, I2 = 99%). Pooled
prevalences of PH were 17% (14–20%; I2 = 99%) for 34
community cohorts, 19% (15–25%; I2 = 98%) for 23 primary
care cohorts and 31% (15–50%; I2 = 0%) for three nursing/
residential care home cohorts (P = 0.16 for between group
differences, see Fig. 2). When low quality studies were
omitted from analyses, pooled prevalences of PH were 18%
(15–23%; I2 = 99%) for 20 community cohorts, 22%
(18–26%; I2 = 93%) for 10 primary care cohorts and 20%
(17–22%; I2 = 0%) for two nursing/residential care home
cohorts (P = 0.38 for between group differences).
Table 2 Studies included in meta-analysis for consensus definition of postural hypotension (Continued)
Study Subjects Age (mean or range;
years)
BP measurement method Prevalence
of PH (%)




Male and female individuals, aged over 60 years,
living in the community (day care centres, nursing
homes and institutions were included) who were
citizens or permanent residents in Singapore
> 60.0 Two sitting BP measurements were
recorded and the mean was used for
analysis. Standing BP was also
measured after 2 min using a standard
electronic sphygmomanometer





Male and female Korean individuals, aged
40–69 years, living in an industrialised community
32 km southwest of Seoul, South Korea (Ansan)
and in a rural setting, 100 km south of Seoul (Ansung)
40.0–69.0 After at least 5 min of supine rest, BP
was measured 3 times at 30 s intervals
and the mean was used for analysis.
Standing BP measurements were





Male and female individuals, aged over 60 years,
with isolated systolic hypertension (sitting SBP
160–219 mmHg, DBP < 95 mmHg and a standing
SBP ≥ 140 mmHg)
70.0 BP was measured twice after 2 min of
rest in the supine position, twice after
5 min of rest in the seated position






Male and female individuals, aged over 18 years,
living in Cantabria, Spain
48.5 After 5 min of rest, 3 BP
measurements in the dominant arm
were recorded in the sitting position
using the validated and
semiautomatic device (Omron 705 CP;
Peróxidos Farmacéuticos S.A.
Barcelona, Spain) and the mean of the
final 2 measurements were used for
analysis. BP was also measured at 1




Male and female, home-dwelling and
institutionalised individuals, born in 1920 or earlier
and living in 5 rural municipalities around the
town of Oulu, Northern Finland
> 70.0 After 5 min of supine rest and at 1
and 3 min after standing, BP was
measured in the right arm. The BP




Male and female community-dwelling individuals,
with normal glucose tolerance, pre-diabetes and
diabetes, aged ≥20 years, living in Tainan, a city
in southern Taiwan
≥ 20.0 Two seated BP measurements were
recorded, with at least 5 min intervals,
after at least 15 min rest using a DINA
MAP vital sign monitor (model
1846SX; Critikon, Irvine, CA). BP was
also measured twice in the supine
position followed by measurements at




Male and female individuals, aged over
55 years, living in the south-east region of
Singapore
65.5 After at least 10 min of rest, BP was
measured up to 3 times, at 30 s
intervals, in the right arm in the
supine, seated and standing positions
using a standard mercury
sphygmomanometer. The mean of
the two closest readings was used for
analysis
16.6
BP blood pressure, s seconds, min minutes
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For disease subgroups, pooled prevalences of PH were
19% (16–23%; I2 = 98%) in hypertension (20 cohorts),
21% (16–26%; I2 = 92%) in diabetes (four cohorts), 25%
(18–33%; I2 = 88%) in Parkinson’s disease (seven co-
horts) and 29% (25–33%; I2 = 0%) in dementia (three co-
horts), compared with 14% (12–17%; I2 = 99%) for those
without these conditions (26 cohorts; P < 0.01 for be-
tween group differences; Fig. 3.). When low quality stud-
ies were omitted from analyses, pooled prevalences of
PH were 21% (17–26%; I2 = 98%) in hypertension (10 co-
horts), 21% (16–26%; I2 = 92%) in diabetes (four co-
horts), 29% (16–44%; I2 = 91%) in Parkinson’s disease
(four cohorts) and 29% (27–31%; I2 = 0%) in dementia
(one cohort), compared with 17% (13–21%; I2 = 99%) for
those without these conditions (13 cohorts; P < 0.01 for
between group differences).
Where the consensus definition of PH was reported
at study level, prevalence estimates were higher (23%;
19–27%) than those definitions of PH that were not
reported as the consensus definition, but fell within
the scope of the definition at study level (16%; 14–
19%; P = 0.01); this finding persisted on exclusion of
low quality studies (P = 0.04). Sensitivity analyses re-
vealed that the overall PH prevalence was not signifi-
cantly affected by the type of BP measurement device
[auscultatory, 17% (13–21%) or oscillometric, 18%
(15–21%); P = 0.65, see Fig. 4.], or when measured
from a seated (15%; 9–22%) rather than supine (19%;
16–22%) resting position (P = 0.24, see Fig. 5.). When
low quality studies were omitted, there remained no
difference in PH prevalence between seated (22%; 13–
34%) and supine (20; 16–24%) BP measurement
methods (P = 0.67). Heterogeneity remained high
across all subgroups (e.g. setting, disease, PH defin-
ition and measurement method) and was not ex-
plained by the sensitivity analyses according to study
quality. Egger tests (P < 0.01) and visual inspection of
funnel plots suggested possible publication bias
against low prevalence small studies (Fig. 6).
Univariable meta-regression showed three study level
factors to be associated with mean prevalence of PH: age
(P < 0.01), history of falls and disease status (all P < 0.05,
see Table 4). For multivariable analysis, age (Fig. 7.)
and presence of diabetes remained as predictors of PH
(P < 0.01, P = 0.13, respectively; R2 = 36%).
Discussiones
Summary
This is, to our knowledge, the first systematic review
and meta-analysis to present estimates of PH preva-
lence in populations regularly encountered in primary
care, including general practices and related out-
patient clinics, care or nursing homes and community
settings. Our findings confirm that PH, when tested
for, is a common finding across care settings and dis-
ease subgroups, with the highest prevalences observed
in people residing in care/nursing homes (and pri-
mary care, when low quality studies were omitted
from analyses), and in those with dementia; age itself
appears to be the key predictor of prevalence. The
definition of PH used can impact prevalence estimates
and therefore must be considered carefully in clinical
practice. The type of BP measurement device and
Fig. 2 Summary of the prevalence of postural hypotension according to the consensus definition across care settings
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resting position does not appear to systematically
impact PH prevalence estimates.
Strengths and limitations
This study provides insight into PH prevalences across a
variety of care settings and disease cohorts. Our search
terms were intentionally broad, thus it is unlikely that
substantial numbers of relevant publications were
overlooked. Data extraction was limited to English lan-
guage papers and published records, although non Eng-
lish language and Grey literature data generally have
been shown to make limited impact on review findings
where a substantial body of published evidence exists
[81]. We found some evidence for publication bias against
low prevalence small studies; overall, there was consider-
able heterogeneity of PH prevalence estimates across
Fig. 3 Prevalence of postural hypotension according to the consensus definition across disease subgroups. ‘Control’ group represents those
individuals with no co-morbidity
McDonagh et al. BMC Family Practice            (2021) 22:1 Page 15 of 23
different care settings, disease cohorts, PH definitions and
BP measurement methods that was not accounted for in
our sensitivity analyses. The utility of the NOS for asses-
sing study quality has previously shown poor agreement
between reviewers, with calls for more specific guidance
in its use [82]. We adapted the generic guidance to give
context specific to this PH review (Appendix 2), however,
we did not find any substantial impact on heterogeneity in
subgroup analyses according to quality assessment of
studies. High residual levels of heterogeneity limit our
ability to draw firm conclusions from the data. PH preva-
lence varied widely across studies (2.0–56.8%) and residual
heterogeneity probably reflects cumulative effects of non-
systematic variations in population size and health status,
limitations in classifying cohorts by condition at study
level, and the discrepancy in PH definitions and measure-
ment methods employed across studies.
Our univariable meta-regression showed that the
presence of disease was associated with increasing PH
prevalence, according to condition. This association did
not persist when multivariable regression was undertaken,
but there was co-linearity of disease status with diabetes,
which was included a priori in the multivariable model.
Increasing BP per se, a known risk factor for orthostatic
Fig. 4 Summary of the prevalence of postural hypotension according to the consensus definition across different measurement methods (auscultatory vs.
oscillometric techniques)
Fig. 5 Summary of the prevalence of postural hypotension according to the consensus definition across different resting positions (supine vs.
seated techniques)
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hypotension [83], was not associated with increasing PH
incidence; however, data for baseline BP were, sur-
prisingly, only reported in 13 studies, limiting our ability
to explore this association. The relationship of PH with
hypertension is complex; PH is associated with both
uncontrolled hypertension and the number of
antihypertensive drugs used in managing high BP [25, 38,
84, 85], but effective treatment of high BP in elderly per-
sons is associated with reduced PH prevalence [41, 86].
Consequently, a non-linear or ‘U’ shaped relationship of
prevalence to absolute BP might be expected, with inter-
action in analyses between a diagnosis of hypertension
Fig. 6 Funnel plot for prevalence of postural hypotension (defined as a drop in systolic blood pressure of ≥20mmHg or diastolic blood pressure
of ≥10mmHg within three minutes of rising to a standing position). Egger test (P < 0.01)
Table 4 Univariable regression-analyses
Variable P-value 95% CI Coefficient Studies reporting variable (n)
Age P = 0.001 0.002 to 0.009 0.0057 38
Gender P = 0.086 −0.000 to 0.004 0.0016 55
Diabetes P = 0.434 −0.000 to 0.002 0.0005 42
Hypertension P = 0.153 −0.000 to 0.002 0.0009 49
BMI P = 0.863 −0.032 to 0.038 0.0028 13
Coronary heart disease P = 0.161 −0.003 to 0.014 0.0057 8
Stroke P = 0.336 −0.005 to 0.014 0.0045 21
Parkinson’s P = 0.993 −0.001 to 0.001 0.0000 19
Falls P = 0.025 0.001 to 0.014 0.0073 12
Setting P = 0.437 −0.187 to 0.043 0.0121 60
Disease status P = 0.033 0.002 to 0.381 0.0198 60
Blood pressure position P = 0.470 −0.043 to 0.091 0.0243 58
Blood pressure device P = 0.869 −0.059 to 0.069 0.0053 53
Seated systolic blood pressure P = 0.797 −0.008 to 0.009 0.0009 7
Seated diastolic blood pressure P = 0.530 −0.039 to 0.227 0.0008 7
Supine systolic blood pressure P = 0.129 −0.003 to 0.165 0.0067 6
Supine diastolic blood pressure P = 0.265 −0.189 to 0.052 0.0165 6
95% CI 95% confidence interval
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(indicating treatment) and absolute BP values. Exploration
of such a relationship was not possible in the current
analyses.
Current guidelines for postural hypotension manage-
ment recommend clinicians undertake a comprehensive
medication review if systolic BP falls by 20mmHg on
standing [6]. The de-escalation of antihypertensive medi-
cation is a common treatment method and may increase
the probability of recovery from postural hypotension
with no increased risk of adverse cardiovascular events
[87], however, further work in this area is required.
Comparison with existing literature
This review builds on existing reviews that have sum-
marised prevalence of PH in specific cohorts, such as
those with diabetes or Parkinson’s disease and individuals
over 60 years of age [13, 88–91]. Here, we report that PH
affects 18% of individuals across care settings and disease
cohorts. Our data show that PH incidence rises from
community care settings to those attending primary
care and residing in institutions. These findings reflect
the likelihood that multimorbidity, and the subsequent
risk of PH, is more common in care/nursing home set-
tings than general practices or in the community [92].
We also found that individuals with chronic disease
have increased prevalence estimates of PH compared to
groups without such diseases present. This may be due
to a number of factors, including medication (e.g.
diuretics, antihypertensives), development of peripheral
and/or autonomic neuropathy (associated with diabetes
mellitus and dementia) or physical deconditioning (due
to age-related changes or continued bed rest) [4].
There appears to have been an exponential rise in
interest in PH, with ~ 70% of the studies reported in
this review published in the last decade and ~ 50% in
the last 5 years. This may reflect interest in rising
longevity, multimorbidity and rates of diabetes (risk
markers for PH) [93, 94]. Recent reporting of im-
proved cardiovascular outcomes with intensive lower-
ing of BP is also relevant [95, 96], given the risks of
adverse events such as PH and falls, associated with
lower BP targets [97].
Our findings are consistent with studies that have re-
ported high prevalences of PH in individuals with dia-
betes (type 1, 19% and type 2, 20%) [88], and in the aged
[98]. Prevalences approaching 50% have been reported
in Parkinson’s disease with low prevalence of orthostatic
symptoms, making the case for routine postural BP
testing when reviewing all sufferers [99].
On subgroup analyses, we found no significant differ-
ence in PH prevalence when measuring BP in the
sitting position rather than supine, prior to standing,
and this finding remained on exclusion of low quality
studies. This approach may therefore be justified as
Fig. 7 Bubble plot of study level association between mean age and prevalence of postural hypotension according to the consensus definition (systolic
≥20mmHg or diastolic ≥10mmHg within three minutes of standing). Circles represent estimates from each study, sized according to precision of estimate
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an alternative to the gold-standard supine-to-stand
approach, if undertaken with rigid methodology. Shaw
et al. have previously suggested that the sit-to-stand
method is a good alternative for busy clinicians when
the supine-to-standing method cannot be achieved;
they proposed reducing diagnostic thresholds for PH
to a systolic drop ≥15mmHg or a diastolic drop ≥7mmHg
to maximise the sensitivity and specificity of the test
and to reflect the reduced orthostatic stress of
moving from sitting to standing, compared with lying
supine [100]. We found no evidence to support a
change in diagnostic threshold in this review, but sug-
gest future studies should directly compare supine
versus seated followed by standing PH measurement
methods. We also found that adopting auscultatory or
oscillometric methods of measuring BP did not impact
prevalence estimates. Further work is required across lar-
ger cohorts to determine the most appropriate diagnostic
criteria for PH in primary care if the pragmatic sit-to-
stand method is to be adopted.
When the definition of PH did not fulfil the consensus
description, but fell within its parameters, we found that
prevalence was underestimated irrespective of study
quality. This highlights the importance of adopting the
consensus definition to minimise under-detection of PH
whenever possible [1].
Implications for research and/or practice
Our univariable regression analyses confirmed that an in-
creasing PH prevalence is strongly associated with increas-
ing age, with age-related chronic diseases and with previous
falls. Multivariable analyses revealed that increasing age and
presence of diabetes were particularly associated with in-
creased PH prevalence; such individuals may benefit from
routine checking for postural hypotension. The population
is aging [101], and people are living for longer periods in
older age with levels of dependency, or in care settings
[102]. European hypertension guidelines, recommend
checking for PH in older people, and this will include
greater numbers, with attendant workload pressures, over
time [7, 16]. By describing the commonly encountered
disease states and care settings associated with higher than
background prevalences of PH, we provide evidence to
encourage improved recognition of this condition through
targeted testing. Ideally, BP should ideally be measured from
supine to standing using auscultatory methods and our
results support the use of the consensus definition [1, 80].
Pragmatically, however, the sit-to-stand method may
also be employed as an alternative to the gold standard if
the methods are rigorous [100]. However, further work
comparing supine versus seated followed by standing
measurement methods should be undertaken to clarify
the most approach resting positions and thresholds
for accurate PH diagnosis.
Conclusion
Overall, these findings demonstrate the substantial preva-
lence of PH across a range of populations and care settings
relevant to primary care. Our prevalence findings suggest
that checking for the presence of PH should be routinely
considered when treating chronic conditions, such as dia-
betes, particularly in older persons. Failure to follow the con-
sensus definition of PH appears to underestimate prevalence,
therefore we advocate adoption of the consensus as a stand-
ard whenever checking for PH. Further work is needed to
confirm the diagnostic thresholds for postural hypotension
when BP is measured in the seated rather than supine
position.
Appendix 1
Search strategy (Medline and Embase)
1 postural hypotension.mp. [mp = ti, ab, hw, tn, ot, dm,
mf, dv, kw, fx, nm, kf, px, rx, ui, sy]
2 orthostatic hypotension.mp. [mp = ti, ab, hw, tn, ot,
dm, mf, dv, kw, fx, nm, kf, px, rx, ui, sy]
3 prevalence.mp. [mp = ti, ab, hw, tn, ot, dm, mf, dv,
kw, fx, nm, kf, px, rx, ui, sy]
1 or 2
3 and 4
Limit 5 to human
Appendix 2
Newcastle-Ottawa Scale adapted for cross-sectional stud-
ies for review of postural hypotension prevalence
Selection: (Maximum 5 stars (5 points))
Covidence key: 0 stars = High ROB
1 or 2 stars = Low ROB
Cannot tell = Unclear ROB
1) Representativeness of the sample:
a) Truly representative of the average in the target
population. * (all subjects or random sampling)
b) Somewhat representative of the average in the
target population. * (non-random sampling)
c) Selected group of users.
d) No description of the sampling strategy.
2) Sample size:
a) Justified and satisfactory (a subjective
judgement). *
b) Not justified (important mainly if low sample
size e.g. < 100).
3) Non-participants:
a) Comparability between respondents and non-
respondents characteristics is established, and
the response rate is satisfactory. *
b) The response rate is unsatisfactory, or the
comparability between respondents and non-
respondents is unsatisfactory.
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c) No description of the response rate or the
characteristics of the responders and the non-
responders.
4) Ascertainment of the exposure (i.e. measurement of
sitting/lying and standing blood pressure):
a) Validated measurement tool. **
b) Non-validated measurement tool, but the tool is
available or described.*
c) No description of the measurement tool.
Comparability: (Maximum 2 points)
1) The subjects in different outcome groups are
comparable, based on the study design or
analysis. Confounding factors are controlled. In
this context it is controlling for co-variates.
Reported prevalence may be reported as unadjusted
(usual) with logistic regressions or adjusted. Can indicate
which in extraction. Go for unadjusted or adjusted?
a) The study controls for the most important factor
(systolic BP or Age probably both important). *
b) The study control for any additional factor
(candidates include BMI, BP, age, gender use of
antihypertensive medication). *
Outcome: (Maximum 3 stars)
The outcome for this review is the prevalence of pos-
tural hypotension:
1) Assessment of the outcome:
a) Independent blind assessment. **
b) Record linkage. **
c) Self report. *
d) No description.
These descriptors are unhelpful so suggest re-classify
as:
a) presented as n/N or proportion for each relevant
group in results. **




In this review – the calculation of proportion(s) with
postural hypotension, so should be clearly derived from
n/N without unexpected or unexplained omissions from
numerator or denominator.
a) The statistical test used to analyze the data is
clearly described and appropriate, and the
measurement of the association is presented,
including confidence intervals and the probability
level (p value). *
b) The statistical test is not appropriate, not described
or incomplete.
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PH: Postural hypotension; BP: Blood pressure; NOS: Newcastle-Ottawa Scale
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